Biogen, Inc. (BIIB)

187.24 -4.58 (-2.39%) USD  |  NASDAQ  |  Mar 02, 13:58
More

Biogen Other Income and Expenses (Quarterly)

Other Income and Expenses (Quarterly) Chart

View Other Income and Expenses (Quarterly) for BIIB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Other Income and Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Other Income and Expenses (Quarterly) Range, Past 5 Years

View Other Income and Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Other Income and Expenses (Quarterly) Benchmarks

View Other Income and Expenses (Quarterly) Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
AbbVie, Inc. Upgrade
Stoke Therapeutics, Inc. Upgrade
Merck & Co., Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade